Edgewell Personal Care Company (EPC) — Fair Value Analysis

Base-case fair value (P50): $13.34 · Current price: $16.00 · Verdict: Overvalued

The Verdict on EPC

EDGEWELL PERSONAL CARE (EPC) is currently assessed as Fairly Valued based on our Monte Carlo simulations. While the current market price of $16.00 sits above our median fair value (P50) of $13.34, reflecting an -16.6% difference, this falls within the acceptable range for a "Fairly Valued" assessment. Our comprehensive analysis, integrating thousands of forward-looking scenarios, indicates that the market's current valuation of EPC is broadly consistent with the underlying fundamentals, despite the apparent premium to the P50.

How EPC stacks up against peers

EPC's fair value assessment must also consider its operational and financial health. The company is categorized with a weak quality tier when compared to its sector peers. This weak standing suggests potential challenges or lower resilience in its business operations and financial structure. The Monte Carlo simulations incorporate these fundamental weaknesses, influencing the fair value calculation and leading to a median fair value $13.34 that is -16.6% below the current market price of $16.00. Investors should weigh this quality tier heavily against the current valuation.

What this means for investors

For investors tracking EDGEWELL PERSONAL CARE, the assessment of Fairly Valued suggests that the stock is neither a compelling buy nor a strong sell opportunity at its current price of $16.00. Despite $16.00 trading -16.6% above the $13.34 fair value, the overall Monte Carlo distribution, combined with EPC's weak quality tier, supports this balanced verdict. FairCurve's analysis underscores that while the stock isn't significantly mispriced, the weak fundamentals could introduce volatility. To gain deeper insights into EPC's full bear and bull case distribution and track its fair value as new fundamental data is released, sign up for a free FairCurve account.